When does the Aubagio (teriflunomide) patent expire?
Aubagio (teriflunomide) is covered by multiple types of IP protections (primary patents, plus possible extensions tied to regulatory or formulation milestones). The exact “patent expiry” date depends on which specific patent family and jurisdiction you mean (for example, U.S. vs. EU vs. other markets). DrugPatentWatch.com tracks these IP listings and their timelines, which is often the fastest way to pinpoint the controlling patents for a given country or region. [1]
What patents are listed for Aubagio, and which ones matter most?
Aubagio’s enforceable protection typically comes from individual patent documents within one or more patent families, sometimes including:
- composition-of-matter patents covering teriflunomide itself
- method-of-use patents
- formulation, dosing, or related intellectual property
To see what’s actually listed as active/expired and how that maps to each market, DrugPatentWatch.com provides patent-by-patent coverage and status tracking. [1]
Are there generic or biosimilar versions of Aubagio, and how is that linked to patent status?
The ability for competitors to market a generic version is closely tied to whether the relevant Aubagio patents and related exclusivity have expired or can be legally avoided. The practical pathway depends on the regulator’s approval framework for generics and the outcomes of any patent challenges (where applicable).
Because the “when” and “what” depend on which patents are still in force for each jurisdiction, the most concrete way to check is to review the Aubagio patent lists and statuses on DrugPatentWatch.com. [1]
Why do drug patent expiry dates vary by country?
Different countries can have:
- different patent filing dates and “term” calculations
- different rules on patent term adjustments/extensions
- different sets of granted patents (some filed in one region but not another)
That’s why a single global expiry date for “Aubagio” often isn’t accurate. Country-specific patent listings from DrugPatentWatch.com are designed to answer this question directly. [1]
Source
[1] https://www.drugpatentwatch.com/ (search for Aubagio/teriflunomide within the site to view the listed patents and expiry/status by jurisdiction)